Free Trial

Cidara Therapeutics (CDTX) SEC Filings & 10K Form

Cidara Therapeutics logo
$23.05 -1.85 (-7.43%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$23.24 +0.18 (+0.80%)
As of 03/3/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cidara Therapeutics SEC Filings

DateFilerForm TypeView
02/26/2025
5:31 PM
Cidara Therapeutics (Issuer)
KARBE FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:24 PM
Cidara Therapeutics (Issuer)
KARBE FRANK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
5:29 PM
Cidara Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
5:38 PM
Cidara Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:42 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:12 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:02 PM
Cidara Therapeutics (Filer)
Form 424B3
01/01/2025
11:15 PM
Cidara Therapeutics (Filer)
Form EFFECT
12/23/2024
3:39 PM
Cidara Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/19/2024
5:15 PM
Canale-Theakston Carin (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:17 PM
Bassler Bonnie L (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:18 PM
Cidara Therapeutics (Issuer)
Mineo Chrysa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:19 PM
Cidara Therapeutics (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:20 PM
BURGESS DANIEL D (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:37 PM
Cidara Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
12/03/2024
3:34 PM
Cidara Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
11/29/2024
3:15 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:32 PM
Cidara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
10/02/2024
4:19 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:25 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:27 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:30 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
7:10 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
5:26 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:27 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:35 PM
Cidara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/13/2024
3:19 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:15 PM
Cidara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
11:15 PM
Cidara Therapeutics (Filer)
Form EFFECT
07/31/2024
4:25 PM
Cidara Therapeutics (Filer)
Form 424B3
07/29/2024
3:45 PM
BCLS Fund III Investments, LP (Filed by)
Cidara Therapeutics (Subject)
Form SC 13G
07/29/2024
3:31 PM
Canaan XII L.P. (Filed by)
Cidara Therapeutics (Subject)
Form SC 13G
07/22/2024
4:09 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4/A
07/22/2024
4:11 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:54 PM
Canale-Theakston Carin (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:54 PM
Cidara Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/19/2024
3:55 PM
Bassler Bonnie L (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:56 PM
BURGESS DANIEL D (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:16 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:49 PM
Cidara Therapeutics (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

07/19/2024
3:52 PM
Cidara Therapeutics (Issuer)
Mineo Chrysa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:53 PM
Cidara Therapeutics (Issuer)
Merson James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:38 PM
Cidara Therapeutics (Issuer)
Tadvalkar Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:40 PM
Cidara Therapeutics (Issuer)
Spencer Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:31 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:26 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:36 PM
Cidara Therapeutics (Filer)
Form DEF 14A
06/03/2024
3:38 PM
Cidara Therapeutics (Filer)
Form DEFA14A
05/23/2024
3:59 PM
Cidara Therapeutics (Filer)
Form PRE 14A
05/15/2024
3:22 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:00 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
3:34 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
3:37 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:07 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:09 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
4:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
7:02 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
7:00 AM
Cidara Therapeutics (Filer)
Form NT 10-K
03/20/2024
5:46 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:47 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:47 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:48 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:48 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:45 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:46 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:47 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:48 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:48 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:22 PM
Cidara Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CDTX) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners